Home › Siemens Healthcare Diagnostics Inc. › Atellica CH ASO_2
Atellica CH ASO_2
Siemens Healthcare Diagnostics Inc. · Model 11097634 · UDI-DI 00630414596167
10
510(k) clearances
5
Adverse events
4
Recalls
36
Facilities
Description
Antistreptolysine O (ASO_2) Atellica CH - RGT 1200T
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2008-11-18 | Remel, Inc | These lots may exhibit false positive reactions with strains of Staphylococcus epidermidis that may result in the mis-identification of Staphylococcus aureus. |
| 2007-08-08 | BD Diagnostic Systems / Lee Laboratories | Incorrect result: The product exhibited decreased fluorescence when testing with the homologous control organism. |
| 2006-07-25 | Roche Diagnostics Corp. | The vial containing the R2 reagent is labeled as R1 reagent and if placed in the R1 slot of the analyzer, erroneous results will be obtained. (extremely low patient and control res |
| 2003-12-17 | Beckman Coulter Inc | The ASO (MPE) assayed in Buffer cannot be programmed or calibrated using Array Calculator 5. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.